AM
Therapeutic Areas
Peptris Technologies Private Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PEPR-124 (RT-001) | Duchenne Muscular Dystrophy | Phase 2-ready |
| PEPR111 | Oncology | Lead Optimization |
| PEPR112 | Oncology | Lead Optimization |
| PEPR401 | Inflammation | In-vivo |
| PEPRX101 | Rare Diseases | In-vitro |